US Stock MarketDetailed Quotes
BJDX Bluejay Diagnostics
- 3.5200
- +0.0200+0.57%
Close Nov 22 16:00 ET
- 3.6800
- +0.1600+4.55%
Post 20:01 ET
1.95MMarket Cap-4P/E (TTM)
3.9949High3.3001Low111.25KVolume3.3400Open3.5000Pre Close408.86KTurnover20.16%Turnover Ratio0.00P/E (Static)552.85KShares1564.000052wk High0.27P/B1.94MFloat Cap3.030052wk Low--Dividend TTM551.75KShs Float50000.0000Historical High--Div YieldTTM19.85%Amplitude3.0300Historical Low3.6750Avg Price1Lot Size
Bluejay Diagnostics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -71.67%-1.93M | -25.44%-1.85M | 21.73%-2.3M | -7.39%-8.31M | 5.66%-2.78M | 10.78%-1.13M | 10.93%-1.48M | -56.27%-2.93M | -77.28%-7.74M | -16.69%-2.94M |
| Net income from continuing operations | 35.51%-1.48M | 12.01%-2.48M | 8.32%-2.33M | -7.07%-9.95M | 3.50%-2.3M | 22.36%-2.3M | -45.21%-2.81M | -26.15%-2.54M | -166.52%-9.3M | -63.39%-2.39M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.92%137 | ---- |
| Depreciation and amortization | -80.22%53.57K | -81.70%53.72K | -66.12%54.33K | 154.91%780.96K | -18.28%56.32K | 212.40%270.79K | 255.52%293.5K | 135.08%160.35K | 110.25%306.37K | 75.78%68.93K |
| Other non cash items | --186.14K | --622.18K | --294 | --1.31K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -173.56%-694.87K | -105.94%-60.13K | 95.59%-34.11K | 15.24%666.73K | 30.33%-516.8K | -26.71%944.63K | 1,029.23%1.01M | -1,230.59%-773.7K | 138.95%578.54K | 45.69%-741.83K |
| -Change in prepaid assets | 382.13%148.05K | -126.85%-171.42K | 90.75%-41.32K | 2,371.70%926.22K | 169.89%703.54K | -92.13%30.71K | 140.39%638.5K | -244.06%-446.53K | 97.37%-40.77K | 19.22%-1.01M |
| -Change in payables and accrued expense | -190.51%-825.56K | -64.65%131.61K | 26.79%-240.83K | -142.00%-266.04K | -558.40%-1.22M | 304.06%912.16K | 197.21%372.32K | -162.74%-328.93K | 24,387.86%633.5K | 245.17%266.49K |
| -Change in other current assets | -54.24%809 | -54.30%808 | 95.02%3.45K | 146.14%6.55K | 171.82%1.24K | 10.78%1.77K | 111.91%1.77K | 124.37%1.77K | 32.48%-14.19K | 91.76%-1.73K |
| -Change in other current liabilities | ---18.16K | ---21.13K | ---20.49K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in other working capital | --0 | --0 | --265.08K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -71.67%-1.93M | -25.44%-1.85M | 21.73%-2.3M | -7.39%-8.31M | 5.66%-2.78M | 10.78%-1.13M | 10.93%-1.48M | -56.27%-2.93M | -77.28%-7.74M | -16.69%-2.94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.70%-227 | -34.26%-270K | 89.60%-35.43K | 41.28%-704.17K | 63.10%-87.89K | 90.59%-74.5K | -63.16%-201.11K | -635.06%-340.67K | -4,908.02%-1.2M | -1,243.30%-238.21K |
| Net PPE purchase and sale | 99.70%-227 | -34.26%-270K | 89.60%-35.43K | 41.28%-704.17K | 63.10%-87.89K | 90.59%-74.5K | -63.16%-201.11K | -635.06%-340.67K | -4,908.02%-1.2M | -1,243.30%-238.21K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 99.70%-227 | -34.26%-270K | 89.60%-35.43K | 41.28%-704.17K | 63.10%-87.89K | 90.59%-74.5K | -63.16%-201.11K | -635.06%-340.67K | -4,908.02%-1.2M | -1,243.30%-238.21K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -131.55%-371.05K | 280,833.48%7.52M | 4,834.73%2.78M | -4,055.89%-319.44K | -17,859.13%-1.43M | 1.18M | -2.68K | -58.8K | -99.96%8.08K | -99.96%8.08K |
| Net issuance payments of debt | -30,812.81%-371.57K | 7,193.59%85.19K | -299.92%-4.81K | -500.12%-4.81K | -50.06%-1.2K | ---1.2K | ---1.2K | ---1.2K | -100.02%-801 | ---801 |
| Net common stock issuance | --0 | --8.57M | --3.5M | --159.84K | ---1.43M | --1.59M | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -8.91%28.88K | ---- |
| Net other financing activities | --0 | -76,585.99%-1.13M | -1,134.41%-711.03K | 4,882.65%956.53K | --1.43M | ---413.54K | ---1.48K | ---57.6K | 96.45%-20K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -131.55%-371.05K | 280,833.48%7.52M | 4,834.73%2.78M | 13,665.47%1.11M | -137.77%-3.05K | --1.18M | ---2.68K | ---58.8K | -99.96%8.08K | -99.96%8.08K |
| Net cash flow | ||||||||||
| Beginning cash position | 58.00%8.06M | -60.76%2.66M | -78.17%2.21M | -46.90%10.11M | -61.80%5.08M | -66.75%5.1M | -60.40%6.78M | -46.90%10.11M | 1,987.75%19.05M | 470.33%13.29M |
| Current changes in cash | -9,711.14%-2.3M | 420.98%5.4M | 113.58%452.65K | 11.49%-7.91M | 9.64%-2.87M | 98.86%-23.47K | 5.66%-1.68M | -73.27%-3.33M | -149.26%-8.93M | -118.99%-3.17M |
| End cash Position | 13.37%5.76M | 58.00%8.06M | -60.76%2.66M | -78.17%2.21M | -78.17%2.21M | -61.80%5.08M | -66.75%5.1M | -60.40%6.78M | -46.90%10.11M | -46.90%10.11M |
| Free cash flow | -61.03%-1.93M | -26.49%-2.12M | 28.79%-2.33M | -0.86%-9.02M | 9.96%-2.87M | 41.56%-1.2M | 5.81%-1.68M | -70.22%-3.27M | -103.63%-8.94M | -25.26%-3.18M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data